Oxford Cannabinoid Technologies Holdings Plc
OTC: OCTHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Clarissa Ann Sowemimo-Coker
- Employees
- 5
- Headquarters
- London, United Kingdom
- IPO year
- 2021
- Market cap
- $3.0M
- Website
- https://www.oxcantech.com
Loading OCTHF…
Loading profile data…Frequently asked questions about OCTHF
What does Oxford Cannabinoid Technologies Holdings Plc (OCTHF) do?
Oxford Cannabinoid Technologies Holdings Plc operates as a biopharmaceutical company, specializing in the discovery, development, and eventual market launch of cannabinoid-derived prescription medications. Its leading experimental drug, OCT461201, is a selective CB2 receptor agonist formulated as a solid oral dose. This compound is currently in...
Where does OCTHF trade?
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) trades on the Other OTC.
What sector is OCTHF in?
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oxford Cannabinoid Technologies Holdings Plc?
Clarissa Ann Sowemimo-Coker is the chief executive officer of Oxford Cannabinoid Technologies Holdings Plc (OCTHF).
Where is Oxford Cannabinoid Technologies Holdings Plc headquartered?
Oxford Cannabinoid Technologies Holdings Plc is headquartered in United Kingdom.
Does OCTHF pay a dividend?
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OCTHF go public?
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) completed its initial public offering in 2021.